Tubular morphogenesis by genotoxic therapeutic agents that induce NF-κB activation in human vascular endothelial cells

Angiogenesis

Volumn 2, Issue 4, 1998, Pages 345-356

  Goto, Daisuke ^a   Izumi, Hiroto ^a,b   Ono, Mayumi ^a   Okamoto, Takeshi ^c   Kohno, Kimitoshi ^b   Kuwano, Michihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Doxorubicin; Etoposide; NF B

Indexed keywords

EID: 2342488884     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009252811114     Document Type: Article

References (40)

1. Abbadie C, Kabrun N, Bouali F, et al. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 1993; 75, 899-912.
2. Abe T, Okamura K, Ono M, et al. Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis. J Clin Invest 1993; 92, 54-61.
3. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072, 129-157.
4. Baeuerle PA. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072, 63-80.
5. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12, 141-179.
6. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996; 274, 782-784.
7. DeForge LE, Preston AM, Takeuchi E, et al. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 1993; 268, 25568-25576.
8. Hamanaka R, Kohno K, Seguchi T, et al. Induction of low density lipoprotein receptor and a transcription factor Sp1 by tumor necrosis factor in human microvascular endothelial cells. J Biol Chem 1992; 267, 13160-13165.
9. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86, 353-364.
10. Henderson D, Hurley LH. Molecular struggle for transcriptional control. Nature Medicine 1995; 1: 525-527.
11. Hockenbery DM, Oltvai ZN, Yin XM, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75, 241-251.
12. Holbrook NJ, Fornace A Jr. Response to adversity: molecular control of gene activation following genotoxic stress. New Biol 1991; 3, 825-833.
13. Izumi H, Ono M, Ushiro S, et al. Cross talk of tumor necrosis factor-α and epidermal growth factor in human microvascular endothelial cells. Exp Cell Res 1994; 214, 654-662.
14. Kakeji Y, Maehara Y, Ikebe M, Teicher BA. Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-β levels after treatment with radiation or cyclophosphamide in rat 13762 mammary carcinoma. Int J Radiation Oncol Biol 1997; 37, 1115-1123.
15. Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB J 1992; 6, 2581-2590.
16. Kohno K, Tanimura H, Sato S, et al. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells. J Biol Chem 1994; 269, 20503-20508.
17. Liu ZG, Baskaran R, Lea Chou ET, et al. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 1996; 384, 273-276.
18. Lown JW, Chen HH, Plambeck JA, Acton EM. Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects. Biochem Pharmacol 1982; 31, 575-581.
19. Masuda H, Tanaka T, Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994; 203, 1175-1180.
20. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 1993; 12, 2005-2015.
21. Nakano H, Sugioka K, Nakano M, et al. Importance of Fe2+-ADP and the relative unimportance of OH in the mechanism of mitomycin C-induced lipid peroxidation. Biochim Biophys Acta 1984; 796, 285-293.
22. Ohga T, Koike K, Ono M, et al. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 1996; 56, 4224-4228.
23. Okamoto, T, Benter T, Josephs SF, et al. Transcriptional activation from the long-terminal repeat of human immunodeficiency virus it in vitro. Virology 1990; 177, 606-614.
24. Oliveira IC, Mukaida N, Matsushima K, Vilcek J. Transcription inhibition of the interleukin 8 gene by interferon is mediated by NF-κB site. Mol Vell Biol 1994; 14, 5300-5308.
25. Pourzand C, Rossier G, Reelfs O, et al. The overexpression of Bcl-2 inhibits UVA-mediated immediate apoptosis in rat 6 fibroblasts: Evidence for the involvement of Bcl-2 as an antioxidant. Cancer Res 1997; 57, 1405-1411.
26. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124, 1-6.
27. Ryuto M, Ono M, Izumi H, et al. Induction of vascular endothelial growth factor by tumor necrosis factor a in human glioma cells. Possible roles of Sp1. J Biol Chem 1996; 271, 28220-28228.
28. Sato S, Iwaizumi M, Handa K, Tamura Y. Electron spin resonance study on the mode of generation of free radicals of daunomycin, adriamycin, and carboquone in NAD(P)H-microsome system. Jpn J Cancer Res 1977; 68, 603-608.
29. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10, 2247-2258.
30. Shimizu S, Eguchi Y, Kosaka H, et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 1995; 374; 811-813.
31. Shono T, Ono M, Izumi H, et al. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 1996; 16, 4231-4239.
32. Takahashi K, Sawasaki Y, Ichihata J, et al. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990; 25, 263-274.
33. Teicher BA, Alvarez SE, Huang ZD. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 1992; 52, 6702-6704.
34. Teicher BA, Holden AH, Ara G, et al. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int J Cancer 1995; 61, 732-737.
35. Thanos D, Maniatis T. NF-κB: A lesson in family values. Cell 1995; 80, 529-532.
36. Van Antwerp DJ, Martin SJ, Kafri T, et al. Suppression of TNF-α-induced apoptosis by NF-κB Science 1996; 274, 787-789.
37. Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55, 5187-5190.
38. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anti-cancer agents in cells lacking p21. Nature 1996; 381, 713-716.
39. Wang CY, Mayo MW, Baldwin AS, Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996; 274, 784-787.
40. Yoshida S, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis.Mol Cell Biol 1997; 17, 4015-4023.